Search Results for: HRAS

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PI4K2A phosphatidylinositol 4-kinase type 2 alpha
  • Synthesis of PIPs at the plasma membrane
  • Synthesis of PIPs at the Golgi membrane
  • Synthesis of PIPs at the early endosome membrane
PLA2G4B phospholipase A2 group IVB
  • Acyl chain remodelling of PC
  • Acyl chain remodelling of PS
  • Acyl chain remodelling of PE
  • Acyl chain remodelling of PG
  • Hydrolysis of LPC
  • Synthesis of PA
  • XBP1(S) activates chaperone genes
PLAAT4 phospholipase A and acyltransferase 4
  • Acyl chain remodelling of PE
PLCE1 phospholipase C epsilon 1
  • Synthesis of IP3 and IP4 in the cytosol
  • Nephrotic syndrome and focal segmental glomerulosclerosis
PLCH2 phospholipase C eta 2
  • Synthesis of IP3 and IP4 in the cytosol
PRSS50 serine protease 50
PTPRJ protein tyrosine phosphatase receptor type J
  • Phosphorylation of CD3 and TCR zeta chains
  • Neutrophil degranulation
  • Negative regulation of MET activity
  • Negative regulation of FLT3
RAB5C RAB5C, member RAS oncogene family
  • Golgi Associated Vesicle Biogenesis
  • Neutrophil degranulation
  • TBC/RABGAPs
  • Clathrin-mediated endocytosis
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
RABAC1 Rab acceptor 1
RABGEF1 RAB guanine nucleotide exchange factor 1
  • TBC/RABGAPs
  • RAB GEFs exchange GTP for GDP on RABs
RALGDS ral guanine nucleotide dissociation stimulator
  • p38MAPK events
  • p38MAPK events
  • RAF/MAP kinase cascade
RAP1B RAP1B, member of RAS oncogene family
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • Rap1 signalling
  • MAP2K and MAPK activation
  • Neutrophil degranulation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • MET activates RAP1 and RAC1
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
RAP1GDS1 Rap1 GTPase-GDP dissociation stimulator 1
RAPGEF1 Rap guanine nucleotide exchange factor 1
  • Frs2-mediated activation
  • Frs2-mediated activation
  • Downstream signal transduction
  • MET activates RAP1 and RAC1
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Regulation of signaling by CBL
RASA1 RAS p21 protein activator 1
  • Downstream signal transduction
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • VEGFR2 mediated cell proliferation
  • Regulation of RAS by GAPs
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • RASA1-related disorders, including: Parkes-Weber slndrome; Capillary malformation-arteriovenous malformation (CM-AVM); Arteriovenous fistula (AVF)
RASA2 RAS p21 protein activator 2
  • Regulation of RAS by GAPs
RASA4 RAS p21 protein activator 4
  • Regulation of RAS by GAPs
RASGRF1 Ras protein specific guanine nucleotide releasing factor 1
  • Ras activation upon Ca2+ influx through NMDA receptor
  • RAF/MAP kinase cascade
RASGRP1 RAS guanyl releasing protein 1
  • Effects of PIP2 hydrolysis
  • Activation of RAS in B cells
  • Activation of RAS in B cells
  • FCERI mediated NF-kB activation
  • Integrin signaling
  • Rap1 signalling
  • RAF/MAP kinase cascade
RASGRP4 RAS guanyl releasing protein 4
  • FCERI mediated NF-kB activation
  • RAF/MAP kinase cascade

Page 6 out of 8 pages